Pharma Stock: USFDA Approved for Phytonadione Injectable Emulsion, $18.5M US Market Potential

Pharma Stock USFDA Approved for Phytonadione Injectable Emulsion, $18.5M US Market Potential

Pharma Stock (Company), Caplin Point Laboratories, will be in focus this week because its wholly owned subsidiary, Caplin Steriles Limited has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Phytonadione Injectable Emulsion USP, 10 mg/mL, Single Dose Vial.   Read: Automobile Stocks Under 100 Surge … Read more